Left ventricular (LV) remodeling, which can result from myocardial damage or ventricular
pressure or volume overload, has genomic, cellular, and interstitial components with …

Myocardial infarction (MI) is a major cause of morbidity and mortality in developed countries.
However, significant advances have been made over the past 25 years decreasing its in …

Myocardial infarction (MI) is the leading cause of death and morbidity worldwide, with an
incidence relatively high in developed countries and rapidly growing in developing …

Heart failure secondary to myocardial infarction (MI) remains a major source of morbidity
and mortality. Long-term outcome after MI can be largely be defined in terms of its impact on …

Cardiac remodeling remains an important primary therapeutic target in patients with
myocardial infarction (MI) and chronic heart failure. It also has utility as a reliable surrogate …

Left ventricular (LV) remodelling remains an important treatment target in patients after
myocardial infarction (MI) and chronic heart failure (CHF). Accumulating evidence has …

This review briefly highlights the major mechanisms of left ventricular (LV) remodeling
following myocardial infarction in heart failure and presents novel strategies to limit infarct …

Medical advances in the care of cardiac patients have resulted in more patients surviving an
acute myocardial infarction (MI) than ever before. Each year hundreds of thousands of these …

The remodeling of the left ventricle occurs as a response to a number of pathophysiologic
events. It commonly occurs after a myocardial infarction as a response to loss of muscle …

Over the last 50 years, studies investigating the pathogenesis of left ventricular dysfunction
have resulted in many potential therapeutic targets being identified and novel classes of …